FAQs
Q1. What is Hydroquinone in Lumacip HQ Depigmenting Complex and how does it work differently from cosmetic brighteners?
A1. Hydroquinone is a pharmaceutical-grade depigmenting agent with the longest clinical evidence base of any skin lightening ingredient. It inhibits tyrosinase (the enzyme that converts tyrosine to melanin precursors) more potently than cosmetic brighteners — and, unlike purely competitive enzyme inhibitors like Arbutin, Hydroquinone also has a cytostatic effect on melanocytes, reducing their overall pigment-producing capacity. This is why Hydroquinone produces faster and more pronounced depigmentation than multi-brightener cosmetic formulas. Lumacip HQ is a medically-oriented product and should be used under dermatologist supervision — prolonged unsupervised use carries risks of rebound hyperpigmentation (ochronosis) particularly in darker skin tones, which is why Hydroquinone therapy is typically used in defined cycles rather than indefinitely.
Q2. What is Tetrahydrocurcumin in Lumacip HQ and why is it used instead of regular Curcumin?
A2. Tetrahydrocurcumin (THC) is a hydrogenated, colourless metabolite of Curcumin (the yellow pigment from turmeric). The hydrogenation process removes the double bonds responsible for Curcumin's yellow colour and instability, producing a white compound with superior antioxidant potency (studies show THC has 2–4 times greater free-radical scavenging activity than Curcumin), better chemical stability in cosmetic formulas, and improved skin penetration. THC also inhibits melanogenesis through multiple pathways: tyrosinase inhibition, MITF transcription factor suppression, and reduction of oxidative melanin stimulation. In Lumacip HQ, THC amplifies the depigmenting effect of Hydroquinone while simultaneously providing antioxidant protection against the UV-triggered free radicals that drive ongoing pigmentation.
Q3. Why does Lumacip HQ include Kojic Acid Dipalmitate, Beta Arbutin, AND Lactic Acid alongside Hydroquinone?
A3. Lumacip HQ employs a comprehensive multi-pathway approach to depigmentation. Kojic Acid Dipalmitate (the more stable ester form of Kojic Acid) chelates the copper cofactor of tyrosinase — inhibiting it via a completely different mechanism from Hydroquinone's direct enzyme competition. Beta Arbutin provides a third tyrosinase inhibition mechanism. The combination of three independent tyrosinase inhibitors means the melanin production pathway is blocked at multiple concurrent points, making the overall depigmenting effect more comprehensive and reducing the ability of melanocytes to compensate for any single blocked pathway. Lactic Acid adds gentle exfoliation that accelerates the shedding of melanin-loaded corneocytes, visibly brightening skin tone faster by removing surface pigment while the active ingredients reduce new melanin production below.
Q4. Is Lumacip HQ Depigmenting Complex safe for Indian skin tones and how should it be used responsibly?
A4. Lumacip HQ should be used under the supervision of a dermatologist in India. Hydroquinone is an effective treatment for melasma and PIH — both extremely common in Indian skin — but carries risk of exogenous ochronosis (paradoxical bluish-black discolouration) with unsupervised prolonged use, particularly in darker Fitzpatrick types (IV–VI). Dermatologist-supervised use typically involves defined treatment cycles of 8–12 weeks followed by a rest period, with combination SPF50+ and often paired with a low-potency retinoid or AHA to enhance efficacy and allow lower Hydroquinone concentrations. Self-prescribed continuous use is strongly discouraged.
Q5. How quickly does Lumacip HQ Depigmenting Complex produce visible results for melasma and dark spots?
A5. Hydroquinone-containing formulas typically produce initial visible lightening within 4–6 weeks of consistent twice-daily use — faster than purely cosmetic brightening products because of Hydroquinone's pharmaceutical-grade tyrosinase potency. Significant melasma improvement is typically observed at 8–12 weeks. Surface tan from recent sun exposure responds more rapidly (2–4 weeks) than deep dermal melasma. The Lactic Acid in the formula accelerates visible results by removing surface melanin through exfoliation while the actives work on new melanin production. Daily SPF50+ use is non-negotiable — without UV protection, new melanin formation will persistently overcome depigmenting treatment progress.
